Syndax Pharmaceuticals (SNDX) Operating Margin (QoQ) (2015 - 2026)
Syndax Pharmaceuticals (SNDX) Operating Margin (QoQ) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Syndax Pharmaceuticals | 1.87 Bn | 1.52 Bn | 53.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3,828.00 |
| Dec 31, 2025 | 3,418.00 |
| Sep 30, 2025 | 5,752.00 |
| Jun 30, 2025 | 23,520.00 |
| Mar 31, 2025 | 83,685.00 |
| Dec 31, 2024 | -53,814.00 |
| Sep 30, 2024 | 140,384.00 |
| Dec 31, 2021 | 23,752.00 |
| Sep 30, 2021 | 573,100.00 |
| Jun 30, 2021 | 127,414.00 |
| Mar 31, 2021 | -194,070.00 |
| Dec 31, 2020 | 1,194.00 |
| Sep 30, 2020 | -85,567.00 |
| Jun 30, 2020 | -39,842.00 |
| Mar 31, 2020 | -24,601.00 |
| Dec 31, 2019 | -26,876.00 |
| Sep 30, 2019 | 58,707.00 |
| Jun 30, 2019 | -14,855.00 |
| Mar 31, 2019 | 117,972.00 |
| Dec 31, 2018 | -38,024.00 |